Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,360.00
+28.10 (2.11%)
At close: Dec 5, 2025
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 220.99 billion as of December 5, 2025. Its market cap has increased by 19.72% in one year.
Market Cap
220.99B
Enterprise Value
238.86B
Revenue
30.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,360.00
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 220.99B, an increase of 1,169.78%. That is a compound annual growth rate of 10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 220.99B | -4.00% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | 60.55B | 133.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |